Back
iShares S&P Mid-Cap 400 Value ETF Vs. Gilead Sciences Industry Stock Comparison
Sell
47
IJJ
iShares S&P Mid-Cap 400 Value ETF
Last Price:
123.35
Seasonality Move:
6.06%
Buy
54
GILD
Gilead Sciences
Last Price:
83.61
Seasonality Move:
3.02%
Sell
47
iShares S&P Mid-Cap 400 Value ETF (IJJ)
is a Sell
Is iShares S&P Mid-Cap 400 Value ETF a Buy, Sell or Hold?
- The current iShares S&P Mid-Cap 400 Value ETF [IJJ] share price is $123.30. The Score for IJJ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- IJJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $83.61. The Score for GILD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IJJ Stock Price Chart
What is iShares S&P Mid-Cap 400 Value ETF's stock price today?
-
The iShares S&P Mid-Cap 400 Value ETF share price today is $123.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IJJ is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $83.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing slight selling pressure.
IJJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 58.93 | Buy |
| Chaikin Money Flow: | -73422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.08 - 123.36) | Buy |
| Bollinger Bands (100): | (113.85 - 120.79) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 66.51 | Buy |
| Chaikin Money Flow: | -585562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.57 - 83.53) | Buy |
| Bollinger Bands (100): | (66.1 - 78.82) | Buy |
IJJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.19 | Buy |
| 20-day SMA: | 121.02 | Buy |
| 50-day SMA: | 119.7 | Buy |
| 200-day SMA: | 115.05 | Buy |
| 8-day EMA: | 122.75 | Buy |
| 20-day EMA: | 121.59 | Buy |
| 50-day EMA: | 119.77 | Buy |
| 200-day EMA: | 114.79 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.55 | Buy |
| 20-day SMA: | 81.87 | Buy |
| 50-day SMA: | 77.92 | Buy |
| 200-day SMA: | 73.7 | Buy |
| 8-day EMA: | 83.18 | Buy |
| 20-day EMA: | 81.75 | Buy |
| 50-day EMA: | 78.26 | Buy |
| 200-day EMA: | 74.42 | Buy |
iShares S&P Mid-Cap 400 Value ETF Earnings Growth & IJJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.21 per share, a decrease this year of $2.96 per share, and an increase next year of $3.34 per share.
iShares S&P Mid-Cap 400 Value ETF Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||